Compare ASPN & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASPN | MYGN |
|---|---|---|
| Founded | 2001 | 1991 |
| Country | United States | United States |
| Employees | 854 | 2700 |
| Industry | RETAIL: Building Materials | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.5M | 327.1M |
| IPO Year | 2011 | 1996 |
| Metric | ASPN | MYGN |
|---|---|---|
| Price | $4.91 | $3.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $4.25 | ★ $7.64 |
| AVG Volume (30 Days) | 744.9K | ★ 1.4M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $271,103,000.00 | ★ $771,400,000.00 |
| Revenue This Year | N/A | $6.86 |
| Revenue Next Year | $50.03 | $5.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 2.33 |
| 52 Week Low | $2.30 | $2.74 |
| 52 Week High | $9.35 | $8.59 |
| Indicator | ASPN | MYGN |
|---|---|---|
| Relative Strength Index (RSI) | 39.74 | 37.01 |
| Support Level | $2.99 | $2.83 |
| Resistance Level | $5.48 | $3.31 |
| Average True Range (ATR) | 0.20 | 0.17 |
| MACD | -0.04 | 0.08 |
| Stochastic Oscillator | 6.66 | 40.00 |
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.